Human 3-D tissue models in radiation biology: current status and future perspectives

نویسندگان

  • A. Acheva STUK - Radiation and Nuclear Safety Authority, Laippatie 4, 00880 Helsinki, Finland
  • A. Aerts SCK•CEN - Belgian Nuclear Research Centre, Radiobiology Unit, Boeretang 200, B-2400 Mol, Belgium
  • Ch. Rombouts SCK•CEN - Belgian Nuclear Research Centre, Radiobiology Unit, Boeretang 200, B-2400 Mol, Belgium
  • G. Hildebrandt Department of Radiotherapy and Radiation Oncology, University Hospital Rostock, Südring 75, D-18059 Rostock, Germany
  • K. Manda Department of Radiotherapy and Radiation Oncology, University Hospital Rostock, Südring 75, D-18059 Rostock, Germany
  • M. Kämäräinen STUK - Radiation and Nuclear Safety Authority, Laippatie 4, 00880 Helsinki, Finland
  • S. Baatout SCK•CEN - Belgian Nuclear Research Centre, Radiobiology Unit, Boeretang 200, B-2400 Mol, Belgium
  • S. Salomaa STUK - Radiation and Nuclear Safety Authority, Laippatie 4, 00880 Helsinki, Finland
چکیده مقاله:

In this review, we discuss the use of a variety of 3-D models (particularly 3-D skin, lung, breast and endothelial) in radiobiological research and highlight the differences in responses compared to 2-D culturing conditions (monolayers). We review the characteristics of existing 3-D models and aim to point out the substantial advantages 3-D cultures provide for modern radiobiology. In particular, they may facilitate the shift from the classical DNA damage and repair studies mainly carried out in monolayer cultures to the investigation of more generalized responses through pathway analysis and a system biology approach. 3-D models are expected to be very informative for investigations on radiotherapy responses in addressing the low dose risk. However, the 3-D model systems are not as easy to propagate and standardize as monolayer cultures. Therefore, we discuss the problems and limitations of 3-D models and propose ways to overcome some of the problems.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

human 3-d tissue models in radiation biology: current status and future perspectives

in this review, we discuss the use of a variety of 3-d models (particularly 3-d skin, lung, breast and endothelial) in radiobiological research and highlight the differences in responses compared to 2-d culturing conditions (monolayers). we review the characteristics of existing 3-d models and aim to point out the substantial advantages 3-d cultures provide for modern radiobiology. in particula...

متن کامل

Down Syndrome: Current Status, Challenges and Future Perspectives

Down syndrome (DS) is a birth defect with huge medical and social costs, caused by trisomy of whole or part of chromosome 21. It is the most prevalent genetic disease worldwide and the common genetic cause of intellectual disabilities appearing in about 1 in 400-1500 newborns. Although the syndrome had been described thousands of years before, it was named after John Langdon Down who described ...

متن کامل

Radiation oncology facilities in Turkey: current status and future perspectives.

BACKGROUND AND PURPOSE An analysis of the current radiotherapy status in Turkey was conducted to establish a comprehensive baseline. Turkey's future demand analysis in view of international benchmarks was conducted. Moreover, the ministerial plans are shared to present an example for making a comprehensive planning in developing countries. METHODS The data from all radiotherapy centers in Tur...

متن کامل

Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives

UNLABELLED Trabectedin (ET743, Yondelis(®), manufactured by Baxter Oncology GmbH, Halle/Westfalen, Germany, for Janssen Products, LP, Horsham, PA), derived from the marine ascidian, Ecteinascidia turbinata, is a natural alkaloid with multiple complex mechanisms of action. On 23 October 2015, 15 years after the results of the first Phase 1 clinical trial using trabectedin for chemotherapy-resist...

متن کامل

down syndrome: current status, challenges and future perspectives

down syndrome (ds) is a birth defect with huge medical and social costs, caused by trisomy of whole or part of chromosome 21. it is the most prevalent genetic disease worldwide and the common genetic cause of intellectual disabilities appearing in about 1 in 400-1500 newborns. although the syndrome had been described thousands of years before, it was named after john langdon down who described ...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ذخیره در منابع من قبلا به منابع من ذحیره شده

{@ msg_add @}


عنوان ژورنال

دوره 12  شماره None

صفحات  81- 98

تاریخ انتشار 2014-04

با دنبال کردن یک ژورنال هنگامی که شماره جدید این ژورنال منتشر می شود به شما از طریق ایمیل اطلاع داده می شود.

کلمات کلیدی

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023